Baotou Dongbao Bio-tech announcement: shareholder Baina Shengyuan plans to reduce its shareholding by no more than 11.82 million shares within 3 months after 15 trading days from the date of announcement disclosure, through centralized bidding or bulk trading. The reason for the reduction is capital requirements, and the source of the shares is the shares issued prior to the company's initial public offering and their derivative shares. The reduction price will be determined based on the market price.